Advanced in 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency

Dr. Marwan S. Shinawi

Medical Genetics | Pediatrics
Washington University
1 Childrens Pl, 
Saint Louis, MO 
 (488.7 mi)
Accepting New Patients
Offers Telehealth
Advanced in 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
Washington University
1 Childrens Pl, 
Saint Louis, MO 
 (488.7 mi)
OverviewInsuranceLocationsClinical Research

Overview

Marwan Shinawi is a Medical Genetics specialist and a Pediatrics provider in Saint Louis, Missouri. Dr. Shinawi and is rated as an Advanced provider by MediFind in the treatment of 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency. His top areas of expertise are Hypotonia, Polysyndactyly Cardiac Malformation, Osteopathia Striata Cranial Sclerosis, and Increased Head Circumference. Dr. Shinawi is currently accepting new patients.

His clinical research consists of co-authoring 152 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Specialties
Medical Genetics
Pediatrics
Licenses
Pediatrics in MO
Hospital Affiliations
St Louis Childrens Hospital
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Cox Health
  •  Humana

Locations

WASHINGTON UNIVERSITY
1 Childrens Pl, Saint Louis, MO 63110
Other Locations
WASHINGTON UNIVERSITY
13001 N Outer 40 Rd, 2e St Louis Childrens Specialty Care Cent, Town And Country, MO 63017

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects With A Urea Cycle Disorder With Inadequate Control on Standard of Care
A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects With A Urea Cycle Disorder With Inadequate Control on Standard of Care
Enrollment Status: Terminated
Publish Date: January 25, 2022
Intervention Type: Drug
Study Drug: KB195
Study Phase: Phase 2

152 Total Publications

The DESSH Clinic: A New Multidisciplinary Clinic to Address the Complex Needs of Individuals with a Rare Genetic Disorder.
The DESSH Clinic: A New Multidisciplinary Clinic to Address the Complex Needs of Individuals with a Rare Genetic Disorder.
Journal: Missouri medicine
Published: November 22, 2024

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile